dQ&A's latest diabetes research includes two presentations from our team at ATTD 2026, one of the world's leading stages for diabetes advancements.
Part 1 of dQ&A’s CGM Series charts the rapid global rise of continuous glucose monitoring (CGM) —why uptake is soaring, benefits for patients, and what’s next.
Our 10-year member journeys reveal a powerful window into the diabetes patient experience, showing advances and the challenges that still remain.
A recent patient-reported outcome (PRO) measurement found that reduced hypoglycemia awareness is common in both type 1 and type 2 diabetes.
Discover how self-recorded “diabetes diary” videos can provide researchers truer patient voices than in-person research.
dQ&A helps clients include robust patient-preference studies in FDA regulatory submissions, strengthening decisions that shape diabetes care.
dQ&A launches a new tracking study of Italians with type 1 and type 2 diabetes, capturing real-world insights on care, technology use, and daily challenges.
dQ&A was honored to participate in the 2019 ADA Scientific Sessions with five posters and an abstract highlighting our work.
Our study reveals that perceptions of hypoglycemia profoundly shape life with diabetes, exposing its broad mental, emotional, and physical toll.
